Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study.
Sollena P, Vasiliki N, Kotteas E, Stratigos AJ, Fattore D, Orlandi A, Mannino M, Di Pumpo M, Fida M, Starace M, Apalla Z, Romano MC, Riganti J, Segura S, Martinez AF, Fabbrocini G, Sibaud V, Peris K, On Behalf Of The Eadv Task Force Dermatology For Cancer Patients.
Sollena P, et al. Among authors: fattore d.
Cancers (Basel). 2023 Jul 18;15(14):3658. doi: 10.3390/cancers15143658.
Cancers (Basel). 2023.
PMID: 37509319
Free PMC article.